Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Population-Based Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Saint Petersburg, Russia: Longitudinal Cohort Study

NCT04406038 is registered in ClinicalTrials.gov with European University at St. Petersburg as lead sponsor.

NCT NCT04406038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04406038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Population-Based Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Saint Petersburg, Russia: Longitudinal Cohort Study
Lead sponsor
European University at St. Petersburg
Phase
Observational
Overall status
Completed
Start date
May 27, 2020
Completion date
November 1, 2023
Enrollment
1,038 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19